XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity (Tables)
 9 Months Ended
Jan. 29, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Buyback Activity Under Share Buyback Program

The following table summarizes the Company’s stock buyback activity under this share buyback program:

 

Three Months Ended

 

 

Nine Months Ended

 

(in millions, except share and per share data)

January 29, 2022

 

 

January 30, 2021

 

 

January 29, 2022

 

 

January 30, 2021

 

Shares purchased

 

460,161

 

 

 

—

 

 

 

1,425,190

 

 

 

—

 

Average price per share

$

46.39

 

 

$

—

 

 

$

44.73

 

 

$

—

 

Total cost

$

21.3

 

 

$

—

 

 

$

63.7

 

 

$

—

 
Summary of Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax A summary of changes in AOCI, net of tax is shown below:

 

 

Three Months Ended January 29, 2022

 

 

Nine Months Ended January 29, 2022

 

(in millions)

 

Currency Translation Adjustments

 

 

Derivative Instruments

 

 

Total

 

 

Currency Translation Adjustments

 

 

Derivative Instruments

 

 

Total

 

Balance at beginning of period

 

$

0.8

 

 

$

(2.8

)

 

$

(2.0

)

 

$

11.5

 

 

$

(5.4

)

 

$

6.1

 

  Other comprehensive income (loss)

 

 

(11.1

)

 

 

3.2

 

 

 

(7.9

)

 

 

(21.9

)

 

 

6.5

 

 

 

(15.4

)

  Tax (expense) benefit

 

 

0.1

 

 

 

(0.8

)

 

 

(0.7

)

 

 

0.2

 

 

 

(1.5

)

 

 

(1.3

)

Net other comprehensive income (loss)

 

 

(11.0

)

 

 

2.4

 

 

 

(8.6

)

 

 

(21.7

)

 

 

5.0

 

 

 

(16.7

)

Balance at the end of period

 

$

(10.2

)

 

$

(0.4

)

 

$

(10.6

)

 

$

(10.2

)

 

$

(0.4

)

 

$

(10.6

)

 

 

 

Three Months Ended January 30, 2021

 

 

Nine Months Ended January 30, 2021

 

(in millions)

 

Currency Translation Adjustments

 

 

Derivative Instruments

 

 

Total

 

 

Currency Translation Adjustments

 

 

Derivative Instruments

 

 

Total

 

Balance at beginning of period

 

$

(4.2

)

 

$

(3.7

)

 

$

(7.9

)

 

$

(25.9

)

 

$

(1.0

)

 

$

(26.9

)

  Other comprehensive income (loss)

 

 

18.5

 

 

 

(2.7

)

 

 

15.8

 

 

 

40.5

 

 

 

(6.3

)

 

 

34.2

 

  Tax (expense) benefit

 

 

(0.3

)

 

 

0.6

 

 

 

0.3

 

 

 

(0.6

)

 

 

1.5

 

 

 

0.9

 

Net other comprehensive income (loss)

 

 

18.2

 

 

 

(2.1

)

 

 

16.1

 

 

 

39.9

 

 

 

(4.8

)

 

 

35.1

 

Balance at the end of period

 

$

14.0

 

 

$

(5.8

)

 

$

8.2

 

 

$

14.0

 

 

$

(5.8

)

 

$

8.2

 
Summary of Stock-based Compensation Expense Related to Equity Awards The table below summarizes the stock-based compensation expense related to the equity awards:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

(in millions)

 

January 29, 2022

 

 

January 30, 2021

 

 

January 29, 2022

 

 

January 30, 2021

 

RSUs

 

$

2.6

 

 

$

2.4

 

 

$

7.7

 

 

$

3.4

 

Deferred director awards

 

 

—

 

 

 

—

 

 

 

0.8

 

 

 

—

 

Director awards

 

 

—

 

 

 

—

 

 

 

0.7

 

 

 

0.9

 

Total stock-based compensation expense

 

$

2.6

 

 

$

2.4

 

 

$

9.2

 

 

$

4.3

 

 
2014 Incentive Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of RSA and RSU Activity

The following table summarizes RSU activity under the 2014 Plan:

 

 

Restricted Stock

Units

 

 

Weighted

average grant

date fair value

 

Non-vested at May 1, 2021

 

 

927,611

 

 

$

28.50

 

Awarded

 

 

46,300

 

 

$

48.41

 

Vested

 

 

—

 

 

$

—

 

Forfeited

 

 

—

 

 

$

—

 

Non-vested at January 29, 2022

 

 

973,911

 

 

$

29.45

 
2010 Plan and 2007 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of combined stock option activity and related information for stock options granted

The following table summarizes combined stock option activity under the 2010 Plan and 2007 Plan:

 

 

Shares

 

 

Weighted average exercise price

 

 

Weighted-

average life

(years)

 

 

Aggregate

intrinsic value

(in millions)

 

Outstanding and exercisable at May 1, 2021

 

 

73,000

 

 

$

37.01

 

 

 

3.2

 

 

$

0.6

 

Exercised

 

 

(13,000

)

 

$

37.01

 

 

 

 

 

 

 

 

 

Forfeited

 

 

—

 

 

$

—

 

 

 

 

 

 

 

 

 

Outstanding and exercisable at January 29, 2022

 

 

60,000

 

 

$

37.01

 

 

 

2.4

 

 

$

0.3